Year: 2026

USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth Leader

Written by Customer Service on April 20, 2026. Posted in Mergers And Acquisitions.

Secures One of the Industry’s Most Strategic Operations as the Only Scaled Producer of all Four Magnetic Rare Earth Elements Outside Asia, along with a 15-Year 100% Offtake Agreement with a Special Purpose Vehicle Capitalized by Various U.S. Government Parties, as well as Private Capital Sources and Including Specific Price Floors for Nd, Pr, Dy and Tb Serra Verde Expected to Deliver $550-$650 million of Annualized Run-Rate EBITDA by the end of 20271; Combined Company Expected to Generate c.$1.8 billion of EBITDA in 2030 Combined Company Benefits from a Robust Balance Sheet with Pro-forma Liquidity of c.$3.2 billion2 Best-in-Class Capabilities Across Mining, Processing, Separation, Metallization and Magnet Making with Broad-Based Support from Multiple U.S. Government Agencies and Allies Further Strengthens USA Rare Earth’s Leadership...

NEURONES: Declaration of transactions on treasury shares (April 13 to 17, 2026)

Written by Customer Service on April 20, 2026. Posted in Public Companies.

Nanterre, April 20, 2026 Declaration of transactions on treasury shares(period from April 13 to 17, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between April 13 and 17, 2026 (ISIN code FR0004050250):Day Total daily volume(in number of shares) Weighted average price(unit daily)04/13/2026 6,515 €36.0904/14/2026 6,723 €36.7304/15/2026 6,572 €36.6604/16/2026 5,443 €37.0304/17/2026 22,032 €37.77Total 47,285 As of April 17, 2026, excluding the liquidity contract, NEURONES now holds 381,250 of the 24,328,716 shares comprising the company’s capital (i.e., 1.57%). All press releases relating to the share buyback program are published in the “Regulated Information” section (under “Weekly declarations...

Aktsiaselts Infortar Investor Webinar introducing the results of the Q1 2026

Written by Customer Service on April 20, 2026. Posted in Public Companies.

Infortar will organize a webinar for investors on 4 May 2026 at 12:00 (EET) in Estonian and at 14:00 (EET) in English to introduce the first quarter 2026 results. The webinar will be attended by the Managing Director Martti Talgre and Investor Relations Manager Kadri Laanvee. The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. You can either participate by joining from your web browser or via Microsoft Teams application. When using a smart device to join the webinar, you first need to download the Microsoft Teams application from either Play Store or App Store. Please join the webinar via the following links: 4 May at 12:00 (EET) Estonian webinar4 May at 14:00 (EET) English webinar Questions can be sent to investor@infortar.ee before...

AL Sydbank A/S share buyback programme: transactions in week 16

Written by Customer Service on April 20, 2026. Posted in Public Companies.

Company Announcement No 19/2026Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37 AL Sydbank A/SCVR No DK 12626509, Aabenraaal-sydbank.com20 April 2026 Dear Sirs AL Sydbank A/S share buyback programme: transactions in week 16On 25 February 2026 AL Sydbank A/S announced a share buyback programme of DKK 1,100m. The share buyback programme commenced on 2 March 2026 and will be completed by 31 January 2027. The purpose of the share buyback programme is to reduce the share capital of AL Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under...

Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

Written by Customer Service on April 20, 2026. Posted in Public Companies.

Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on top of standard of care1 Haemoglobin response was superior with etavopivat: 48.7% of people on treatment achieved an increase of >1g/dL after 24 weeks versus 7.2% on placebo1 Novo Nordisk plans to submit for the first regulatory approval of etavopivat in the second half of 2026Bagsværd, Denmark, 20 April 2026 – Novo Nordisk today announced the topline results from HIBISCUS, a pivotal phase 3 trial of once-daily oral etavopivat in adults and adolescents with sickle cell disease (SCD). The results showed that etavopivat successfully met both co-primary endpoints, demonstrating superior reduction in vaso-occlusive crises (VOCs) and superior improvement in haemoglobin (Hb) response compared to placebo. Etavopivat...

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition

Written by Customer Service on April 20, 2026. Posted in Public Companies.

WUHU, China, April 20, 2026 (GLOBE NEWSWIRE) — At the Wuhu round of the Second China Urban Intelligent Driving Competition hosted by D1EV, a leading media platform in the electric and intelligent vehicle sector, the Chery Exeed Sterra ET – equipped with the one‑stage end‑to‑end ADAS (Advanced Driver Assistance System) solution jointly developed by WeRide and Bosch – secured first place by over 10 points, with Horizon Robotics and XPeng taking second and third place. With this victory, WeRide Driving (WeRide WRD 3.0) becomes the first and only solution in the competition’s history to achieve four consecutive wins, reinforcing its technological leadership in complex urban driving environments.WeRide Driving (WRD 3.0) is the first and only solution to achieve four consecutive wins in the Second China Urban Intelligent Driving Competition From...

Consensus estimates ahead of Q1 2026

Written by Customer Service on April 20, 2026. Posted in Public Companies.

Alm. Brand Group hereby publish consensus estimates prior to the announcement of the Q1 results. Consensus estimates are also available via: almbrand.dk Conference Call Alm. Brand Group will report its Q1 2026 results on 28 April at 07:30 CEST and host a conference call with management at 11:00 CEST on the day of release. Dial in for analysts and investors (Conference ID: 177147878): Denmark: +45 80 83 03 77 UK: +44 117 389 0104 USA: +1 585 542 9983 Contact Please direct any questions regarding this announcement to: Investors and equity analysts: Mads Thinggaard – Head of Investor Relations & ESG – mobile no. +45 2025 5469 Press: Mikkel Luplau Schmidt – Head of Communications and Media Relations – mobile no. +45 2052 3883AttachmentsALMB consensus Q126 and 2026_2028 ...

Form 8.3 – [ANIMALCARE GROUP PLC – 17 04 2026] – (CGWL)

Written by Customer Service on April 20, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Form 8.3 – [IDOX PLC – 17 04 2026] – (CGWL)

Written by Customer Service on April 20, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree IDOX PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Share buyback programme – week 16

Written by Customer Service on April 20, 2026. Posted in Public Companies.

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeDanish Financial Supervisory AuthorityOther stakeholders Date 20 April 2026 Share buyback programme – week 16 The share buyback programme runs in the period 2 February 2026 up to and including 8 May 2026, see company announcement of 30 January 2026. During the period the bank will thus buy back its own shares for a total of up to DKK 500 million under the programme, but to a maximum of 600,000 shares. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme...

Year: 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals